Medicare Enrolled

Dr. Neel Srikishen, MD

Surgery · Sugar Land, TX
Low-engagement
16659 SOUTHWEST FWY STE 401, Sugar Land, TX 77479
7134416455
In practice since 2011 (14 years)
NPI: 1912286048 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Srikishen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Srikishen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Srikishen

Dr. Neel Srikishen is a surgery in Sugar Land, TX, with 14 years in practice.

Between the years covered by Open Payments, Dr. Srikishen received a total of $22,867 from 33 pharmaceutical and/or device companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Srikishen is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice$ $22,867 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$22,867
Total received (2018-2024)
Avg $3,267/year across 7 years
Top 13% in TX for surgery
33
Companies
215
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,049 (57.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,569 (41.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$250 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,356
2023
$2,814
2022
$5,233
2021
$449
2020
$639
2019
$2,151
2018
$225

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$7,945
Boston Scientific Corporation
$4,997
Intuitive Surgical, Inc.
$2,446
Coloplast Corp
$1,699
Olympus Corporation of the Americas
$1,499
HISTOSONICS, INC.
$1,000
BIOTISSUE HOLDINGS, INC.
$595
AngioDynamics, Inc.
$413
Endo Pharmaceuticals Inc.
$397
Activ Surgical, Inc.
$250
PROCEPT BioRobotics Corporation
$208
Olympus America Inc.
$188
Ethicon US, LLC
$148
ConvaTec Inc.
$142
180 Medical, Inc.
$119
Progenics Pharmaceuticals, Inc.
$108
Medtronic, Inc.
$104
Axonics, Inc.
$87
BOSTON SCIENTIFIC CORPORATION
$75
COLOPLAST CORP
$70
Teleflex LLC
$48
NeoTract Inc.
$48
Laborie Medical Technologies Corp.
$46
Allergan Inc.
$37
Astellas Pharma US Inc
$36
NxThera, Inc.
$32
Hollister Incorporated
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Ambu Inc.
$18
Teleflex Medical Incorporated
$18
Aroa Biosurgery Incorporated
$18
Renovia Inc
$15
Allergan, Inc.
$15
Top 3 companies account for 67.3% of total payments
Associated products mentioned in payments ›
AMS 700 · AMS 700 CXR RTE Kit · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AVEED · ActivSight · AquaBeam Robotic System · Axonics r-SNM System · BOTOX · CATHETER · CURE CATHETER · DA VINCI SP · Da Vinci Surgical System · EDEX · Enseal X1 · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL FEMALE SUI · GENTLECATH · GREENLIGHT · General - Erectile Dysfunction · General - Kidney Stone Disease · General - Therapies · GentleCath · INTERSTIM · Leva Pelvic Floor Trainer · Ligation Solutions: Weck & Horizon brands · LithoVue · Lumenis Pulse 120H · MYRBETRIQ · Moses 550 DFL · N/A · NANOKNIFE · NEOX · Olympus Digital Flexible Ureteroscopes · Optilume BPH Drug Coated Balloon Catheter · PYLARIFY · REZUM · Rezum · Rezum Generator · SOLERO · SpaceOAR System · SpaceOAR VUE System - 10mL · SpeediCath · TACTRA · Titan · UROLIFT · UroLift · UroLift System · VESICARE · VaPro Plus Pocket · XIAFLEX · Xofigo · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a surgery in Sugar Land?
Compare surgerys in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse surgerys nearby

Geographic Context

Surgerys within 10 mi
452
Per 100K population
52.6
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Srikishen is a surgery, and high industry engagement (low-engagement, top 13%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Srikishen receive payments from pharmaceutical companies?
Yes. Dr. Srikishen received a total of $22,867 from 33 companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Srikishen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →